BiO FrEaK, on Apr 14, 2012 - 14:35, said:
Mahuta i need your help.
Can you pls help me understand how allosteric control of metabolic pathway by end-product inhibition includes negative feedback and non-competitive inhibition? What us an allosteric enzyme'?
Thanks.
Hi,
A metabolic pathway is made up a series of chemical reactions, each catalysed by an enzyme. However, sometimes the product formed from the last reaction will inhibit the enzyme of the first reaction; this is known as end-product inhibition and involves non-competitive inhibitors.
If the end product binds to the enzyme of the first reaction, it will act as a non-competitive inhibitor and will NOT bind to the enzyme's active site but to an allosteric site. The effect of it binding to the allosteric site is that it distorts the shape of the enzyme's active site, meaning that that enzyme is unlikely to be able to catalyse any more chemical reactions. (Note: removing the inhibitor from the allosteric will allow the enzyme's active site to return to its original shape.)
In terms of uses, end-product inhibition is useful to control metabolic pathways, e.g. when there is an excess of a product, the metabolic pathway can be shut down until more of the product is required, at which stage the inhibitor is removed from the allosteric site to restart the metabolic pathway. The term negative feedback is often used as the process opposes a change in the environment and therefore is vital for homeostasis.
Hope this helped,
brofessional (not Mahuta, unfortunately)


Sign In
Create Account
Find content
Female
